The ATA would like to highlight the findings from two recent publications on subclinical thyroid…
Read More
FDA Bioequivalence Workshop Plans continue with ATA, Endocrine Society and AACE leaders 2003-2004 President Clark…
Draft Levothyroxine Workshop Agenda Download Agenda (PDF File, 108 KB) See related articles on Bioequivalence…
FDA invites ATA, TES & AACE to Plan Workshop on Thyroxine Bioequivalence # # #…
ATA Continues Dialog With FDA on Levothyroxine Dose Precision and Bioequivalence Standards 2003-2004 President Clark…
An Assessment of Federal and State Guidelines for the Distribution of Potassium Iodide in the…
ATA asks the FDA to ensure safe and effective levothyroxine preparations April 4, 2003 Mark…
Experts Discuss Potassium Iodide Distribution in Case of Nuclear Incident Download Statement
December 12, 2002 Authorities at government buildings and transportation centers are using portable radiation detectors…
Updated September 28, 2002 On July 12, 2001, the Food and Drug Administration’s (FDA) Center…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.